Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDEA594 plus allopurinol in gout with inadequate response to standard allopurinol
2009-014660-19Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lesinurad and allopurinol in gout (3 arms), sponsored by Ardea Biosciences, Inc. Primary endpoint: Percent reduction from baseline in serum urate after 4 weeks. Started Sep 2009; status: completed.
02
Drugs
lesinuradallopurinol
03
Conditions
gout
Beyond the preview
Go deeper on 2009-014660-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014660-19.